1. Home
  2. LHX vs ILMN Comparison

LHX vs ILMN Comparison

Compare LHX & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo L3Harris Technologies Inc.

LHX

L3Harris Technologies Inc.

HOLD

Current Price

$234.74

Market Cap

44.1B

Sector

Industrials

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$267.26

Market Cap

37.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LHX
ILMN
Founded
1895
1998
Country
United States
United States
Employees
45000
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.1B
37.0B
IPO Year
2002
2000

Fundamental Metrics

Financial Performance
Metric
LHX
ILMN
Price
$234.74
$267.26
Analyst Decision
Buy
Buy
Analyst Count
20
21
Target Price
★ $335.33
$223.85
AVG Volume (30 Days)
1.4M
★ 2.6M
Earning Date
10-29-2026
10-29-2026
Dividend Yield
★ 2.10%
N/A
EPS Growth
8.39
★ 170.87
EPS
★ 5.85
2.22
Revenue
★ $6,182,000,000.00
$4,343,000,000.00
Revenue This Year
$7.98
$6.47
Revenue Next Year
$6.77
$6.40
P/E Ratio
★ $40.64
$122.33
Revenue Growth
★ 4.78
N/A
52 Week Low
$234.59
$88.00
52 Week High
$379.23
$309.35

Technical Indicators

Market Signals
Indicator
LHX
ILMN
Relative Strength Index (RSI) 26.32 60.75
Support Level $234.59 $118.76
Resistance Level $269.50 N/A
Average True Range (ATR) 4.72 15.49
MACD 0.63 1.24
Stochastic Oscillator 11.27 47.00

Price Performance

Historical Comparison
LHX
ILMN

About LHX L3Harris Technologies Inc.

In addition to its legacy software-defined radio franchise, L3Harris Technologies has, through a series of acquisitions, established franchises producing uncrewed aerial vehicles, sensors, avionics, space-based systems, missiles, and solid rocket motors. It is also adept at refitting civilian aircraft for military use, provides military and commercial training services, and maintains the US Federal Aviation Administration's communication infrastructure.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: